Clinical trial
Investigating Immune Escape by SARS-CoV-2 Variants
NCT05171803 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating Immune Escape by SARS-CoV-2 Variants
- Lead sponsor
- University of California, Los Angeles
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 29, 2021
- Completion date
- October 15, 2023
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19; immunity